These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8629259)

  • 21. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
    Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytogenetic and genetic changes in myeloid leukemias and myelodysplastic syndrome].
    Musilová J; Michalová K
    Cas Lek Cesk; 1994 Jun; 133(13):404-6. PubMed ID: 8062333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.
    Olney HJ; Le Beau MM
    Leuk Res; 2007 Apr; 31(4):427-34. PubMed ID: 17161457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in myelodysplastic syndromes.
    Alfaro R; Pérez-Granero A; Durán MA; Besalduch J; Rosell J; Bernués M
    Leuk Res; 2008 Jan; 32(1):159-61. PubMed ID: 17509681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes.
    Jotterand M; Parlier V
    Leuk Lymphoma; 1996 Oct; 23(3-4):253-66. PubMed ID: 9031106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytogenetics of myelodysplastic syndromes.
    Olney HJ; Le Beau MM
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):479-95. PubMed ID: 11640866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Only particular cytogenetic events are related to disease progression in sequential cytogenetic studies in myelodysplastic syndromes.
    Marisavljevic D; Pantic M; Djordjevic V
    J BUON; 2013; 18(2):535-6. PubMed ID: 23818374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
    Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
    Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
    Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
    Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
    Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
    Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
    Mrózek K; Heinonen K; Bloomfield CD
    Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.